Live tape
Top 8, mentions 7d20,002GOOGL8,360 mentions▲ +0.02MSFT2,088 mentions▲ +0.04AMZN1,936 mentions▲ +0.04INTC1,862 mentions▲ +0.03META1,505 mentions▲ +0.03NVDA1,493 mentions▲ +0.06RDDT1,444 mentions▲ +0.04TSLA1,314 mentions▲ +0.05

Equity · Healthcare

MIST

NASDAQ

Milestone Pharmaceuticals (MIST)

0.74 USD −5.53% vs prior close Oct 30, 2026
Milestone Pharmaceuticals Inc. price graph
64 sessions
1.4 0.6 3 Aug 30 Oct

The line runs 1.12 USD on 3 August through 0.74 USD on 30 October, on a scale from 0.6 to 1.4. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
92.1M USD
EPS, diluted, year to Dec 2025
−0.75 USD
52-week range
0.6451 USD – 2.95 USD
Avg volume
32.0K
Mentions, 30 days
33
Net sentiment
+0.01

as of Oct 30, 2026

Have Milestone Pharmaceuticals (MIST) insiders bought or sold shares recently?

MIST has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 16 April 2026.

Form 4

Have Milestone Pharmaceuticals (MIST) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
16 Apr 2026Oliveto JosephPresident and CEOSell36,50082K USD
26 Jan 2026Bharucha DavidChief Medical OfficerSell12,24524K USD
26 Jan 2026Hasija AmitCFO & EVP of Corp. DevelopmentSell12,24524K USD
26 Jan 2026Oliveto JosephPresident and CEOSell34,52367K USD
26 Jan 2026Muller LorenzChief Commercial OfficerSell11,18022K USD
26 Jan 2026Nelson Jeffrey EdwardChief Operating OfficerSell12,24524K USD
08 Jan 2026Oliveto JosephPresident and CEOSell43,00097K USD
07 Jan 2026Oliveto JosephPresident and CEOSell5001K USD
15 Dec 2025Bharucha DavidChief Medical OfficerSell58,007135K USD
15 Dec 2025Hasija AmitCFO & EVP of Corp. DevelopmentSell58,007135K USD
15 Dec 2025Oliveto JosephPresident and CEOSell133,054309K USD
15 Dec 2025Muller LorenzChief Commercial OfficerSell53,566124K USD
Sold13 open-market sales523,079$1.18M

Showing the 12 most recent of 13 open-market trades in this window. The figures above count all of them.

11 other filings: grants, exercises, tax withholding and transfers, not trades
ReportedInsiderTypeSharesValue
26 Jan 2026Bharucha DavidChief Medical OfficerOption exercise20,100
26 Jan 2026Hasija AmitCFO & EVP of Corp. DevelopmentOption exercise20,100
26 Jan 2026Oliveto JosephPresident and CEOOption exercise66,600
26 Jan 2026Muller LorenzChief Commercial OfficerOption exercise20,100
26 Jan 2026Nelson Jeffrey EdwardChief Operating OfficerOption exercise20,100
12 Dec 2025Bharucha DavidChief Medical OfficerAward100,000
12 Dec 2025Hasija AmitCFO & EVP of Corp. DevelopmentAward100,000
12 Dec 2025Oliveto JosephPresident and CEOAward280,000
12 Dec 2025Muller LorenzChief Commercial OfficerAward100,000
12 Dec 2025Nelson Jeffrey EdwardChief Operating OfficerAward100,000
09 Dec 2025Muller LorenzChief Commercial OfficerGift25,000

Which funds hold Milestone Pharmaceuticals (MIST)?

6 of the 45 institutional funds we track reported a Milestone Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined 16.9M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Milestone Pharmaceuticals (MIST)?
FundPositionSharesValueShares q/q
Point72 Asset ManagementAdded5,411,1387.3M USD+398.4%
Millennium ManagementAdded3,142,2194.2M USD+103.5%
Two Sigma InvestmentsHeld (±25%)2,040,0152.7M USD−12.0%
Marshall WaceHeld (±25%)1,797,6952.4M USD−7.6%
Balyasny Asset ManagementTrimmed220,498295K USD−74.1%
Citadel AdvisorsTrimmed32,88744K USD−83.3%
Renaissance TechnologiesExited

What has been filed or recorded for Milestone Pharmaceuticals (MIST)?

The filings we hold for Milestone Pharmaceuticals, newest first: 13 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Milestone Pharmaceuticals (MIST)?
And
14 Oct 2026Fails to deliverShares failed to deliver6,070 shares5K USD notional · 0.005% of shares out
08 Oct 2026Fails to deliverShares failed to deliver4,489 shares3K USD notional · 0.004% of shares out
07 Oct 2026Fails to deliverShares failed to deliver1,395 shares1K USD notional · 0.001% of shares out
05 Oct 2026Fails to deliverShares failed to deliver7,845 shares6K USD notional · 0.006% of shares out
02 Oct 2026Fails to deliverShares failed to deliver38,220 shares31K USD notional · 0.031% of shares out
01 Oct 2026Fails to deliverShares failed to deliver10,268 shares9K USD notional · 0.008% of shares out
30 Sep 2026Fails to deliverShares failed to deliver2,976 shares2K USD notional · 0.002% of shares out
28 Sep 2026Fails to deliverShares failed to deliver83,511 shares66K USD notional · 0.067% of shares out
25 Sep 2026Fails to deliverShares failed to deliver97,011 shares77K USD notional · 0.078% of shares out
24 Sep 2026Fails to deliverShares failed to deliver39,829 shares34K USD notional · 0.032% of shares out
23 Sep 2026Fails to deliverShares failed to deliver98,537 shares91K USD notional · 0.079% of shares out
17 Sep 2026Fails to deliverShares failed to deliver228 shares203 USD notional · <0.001% of shares out
16 Sep 2026Fails to deliverShares failed to deliver807 shares751 USD notional · 0.001% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.21 USDRevenue $1M
30 Jun 2026FinancialsTotal assets181.6M USDat period end
30 Jun 2026FinancialsTotal equity18.2M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.20 USDRevenue $0M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.75 USD
31 Dec 2025FinancialsNet income−63.1M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.75 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.12 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.20 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.31 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −0.67 USD
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.14 USD

What is Reddit saying about Milestone Pharmaceuticals (MIST)?

Reddit mentioned MIST 33 times in the 30 days to 31 October 2026, across 4 of the communities we track. All of them were scored for sentiment: 36% read bullish, 15% bearish and 49% neither. Reddit data updated 31 October 2026.

30-day window, Method

Mentions, 30 days 33Bullish 36%Bearish 15%Communities 4Against the market −18 points

How do Reddit mentions of Milestone Pharmaceuticals (MIST) compare with its price?

Share ↗
Post on X Share on Reddit Share on LinkedIn
33 mentions

Where Milestone Pharmaceuticals (MIST) is discussed

30 days

Where Milestone Pharmaceuticals (MIST) is discussed
CommunityShareMentionsNet sentiment
r/wallstreetbets85%28+0.01
r/ausfinance9%3+0.05
r/etfs3%1+0.03
r/investing3%1−0.25

Moves with Milestone Pharmaceuticals (MIST)

co-mention r, 31 observations

Tickers whose daily Reddit volume rose and fell with Milestone Pharmaceuticals (MIST)'s. Co-discussion, not price.

HYDROGEN +0.95FEAT +0.95JET FUEL +0.93PSI +0.93SHEL +0.92MARS CRUDE +0.90

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method

Milestone Pharmaceuticals (MIST): frequently asked questions

From live data
0.74

What did Milestone Pharmaceuticals shares close at?

Milestone Pharmaceuticals closed at 0.74 USD on 30 Oct 2026, down 5.53% on the close before. That is the end-of-day price from Finazon, not a live quote.

92.1M

What is Milestone Pharmaceuticals’ market cap?

Milestone Pharmaceuticals is worth 92.1M USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.

Have Milestone Pharmaceuticals insiders bought or sold shares recently?

No Milestone Pharmaceuticals insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 16 Apr 2026 (SEC Form 4). See Insiders

6 of 45

Which funds own Milestone Pharmaceuticals?

6 of the 45 funds we track reported a Milestone Pharmaceuticals position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Point72 Asset Management, Millennium Management and Two Sigma Investments. See Funds

−0.21

When did Milestone Pharmaceuticals last report earnings?

Milestone Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.21 USD; no next date is announced in SEC filings yet. See Filings

4 mentions

What is Reddit saying about Milestone Pharmaceuticals?

Milestone Pharmaceuticals was mentioned 4 times in the last 7 days across the finance subreddits we track, and 33 times over the trailing 30 days. Of the 33 mentions scored for sentiment, 36% read bullish and 15% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings